Joanne Imperial, M.D.
Joanne Imperial, M.D. has served as a member of our board of directors since 2025. Dr. Imperial has served as Chief Medical Officer at HepQuant LLC since March 2025 and as Director, Clinical Affairs since November 2024. Dr. Imperial also served as Senior Medical Director for Fortea from September 2020 to October 2024; as Vice President for Blade Therapeutics from February 2019 to September 2020; as Senior Medical Director for Conatus Pharmaceuticals from February 2017 to February 2019; as Medical Director for Fibrogen from August 2014 to February 2017; and as Medical Director, Medical Affairs for Onyx Pharmaceuticals from August 2010 to August 2014. Dr. Imperial also served in various academic and professorship roles at Stanford University from April 1995 to February 2017; and as Clinical Associate Professor at University of California, San Francisco from August 2007 to February 2010. Dr Imperial holds a B.S. in Psychology from Thomas Moore University and a M.D. from New York Medical College. Dr. Imperial completed her residency in medicine and fellowship in clinical nutrition/gastroenterology at New England Deaconess Hospital and also received her fellowship in gastroenterology from University of California, San Francisco.